GPRC5A and breast carcinoma: We found that abundant RAI3 expression in breast cancer (IRS ≥ 5) was not associated with significant alterations in the outcome regarding overall (P = 0.816) and recurrence-free (P = 0.897) survival as shown by Kaplan-Meier analysis (Table 3).